Please find attached amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Artemis Medicare Services has filed an amendment to its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) under SEBI Insider Trading Regulations. The Board of Directors approved the amendments on May 8, 2026. The updated code details norms for prompt disclosure of UPSI, authorized spokespersons (including Chairman, MD, CFO, CBO, Head of Investor Relations, and CPO), procedures for handling selective disclosures, guidelines for analyst meetings, and a legitimate purpose policy for sharing UPSI on a need-to-know basis. The code was originally effective from February 4, 2019. This is a routine regulatory compliance filing to align the company's insider trading policy with current SEBI requirements.
This is a standard regulatory compliance update with no direct impact on the company's financial performance or stock price. It reinforces the company's commitment to transparency and proper handling of price-sensitive information, which is positive for investor confidence in corporate governance.